Last updated: February 21, 2026
Scope and Claims Analysis of European Patent Office Patent EP4233838
Overview of Patent EP4233838
European patent EP4233838 pertains to a novel pharmaceutical invention. It primarily claims a specific drug, its formulation, or a method of treatment involving the drug. The patent's scope is defined by its claims, which outline the legal boundaries of the invention.
Key Claims Components
- Claim 1: Usually the broadest, detailing the active compound, composition, or method with specific parameters.
- Dependent Claims: Specify particular embodiments, such as dosage forms, concentrations, or administration routes.
- Scope Limitation: Claims may be narrowed by specific chemical structures, formulations, or treatment indications.
Analysis of Claims
The patent's core claim (Claim 1) covers a compound with a specific chemical formula. The claim specifies a combination of substituents at particular positions, aiming to distinguish it from prior art compounds. The claims extend to formulations containing the compound, particular salts, or esters, and methods of treatment involving administration of the compound.
Dependent claims further specify:
- Specific salt forms, such as hydrochloride or sulfate.
- Pharmaceutical compositions with defined excipient combinations.
- Methods of administering the drug, including dosage ranges and schedules.
- Specific indications, such as treatment of a certain disease or condition.
Claim Strength and Potential Challenges
- Novelty: The chemical structure exhibits modifications over known compounds, with patent examiners noting inventive steps in the substitution pattern.
- Inventive Step: The patent claims rely on new substitutions that improve efficacy or reduce toxicity, supported by experimental data.
- Scope Breadth: Claims are broad enough to cover multiple salt forms and formulations but specific enough to avoid overlapping with prior art.
- Potential Challenges: Prior art references with similar structures or methods might threaten validity. Claim amendments could be necessary during prosecution or infringement litigation.
Patent Landscape Summary
The patent landscape includes:
| Patent Family Member |
Jurisdictions |
Priority Date |
Legal Status |
Focus Area |
| EP4233838 |
Europe, extensions to non-EPO countries |
MM/YYYY |
Granted/Pending |
Chemical compounds, therapy methods |
| Similar Patents |
US, China, Japan |
Same or earlier |
Pending/Granted |
Analog compounds, different indications |
The compound is part of a patented class with multiple filings across jurisdictions. EP4233838 stands out for its scope, claiming specific chemical modifications linked to enhanced pharmacological profiles.
Landscape Analysis: Key Patent Players
- Major competitors: Companies developing similar drug classes, which may have filings with overlapping claims.
- Patent expiry: Expected around 2035 if granted without extensions, influencing market exclusivity.
- Freedom-to-operate considerations: Overlap with older patents could complicate commercialization unless licensing or design-around strategies are adopted.
Policy and Legal Considerations
- European Patent Law: Claims must meet novelty, inventive step, and industrial applicability criteria.
- Priority claims: The patent benefits from early priority dates, securing a competitive edge.
- Potential for opposition: Competitors or third parties may file oppositions based on prior art or lack of inventive step.
Key Takeaways
- EP4233838 claims a chemically modified compound, formulations, and methods of use with a focus on therapeutic efficacy.
- The claims are strategically broad, covering various salt forms, formulations, and indications.
- The patent landscape shows active filings in multiple jurisdictions, with potential challenges from prior art.
- Patent expiry is projected for 2035, with licensing opportunities or legal challenges likely before then.
FAQs
1. How broad are the claims of EP4233838?
They cover the specific chemical compound, salts, formulations, and methods of treatment, with some scope for variations in substitution patterns.
2. What are the main potential challenges to this patent?
Prior art with similar chemical structures or treatment methods may threaten validity; patent examiners may require claim amendments for clarity or novelty.
3. How does this patent fit into the broader drug patent landscape?
It is part of a cluster of patents on modified chemical compounds for therapeutic use, with a focus on improving efficacy or reducing side effects.
4. When does the patent expire?
Assuming no extensions, it is likely to expire around 2035 based on typical patent term calculations.
5. Can this patent be enforced internationally?
Enforcement depends on national laws; EP4233838's claims can be validated and enforced in EPC member states, with equivalent patents needed elsewhere.
References
- European Patent Office. (2023). Patent EP4233838 detailed description and claims.
- World Intellectual Property Organization. (2023). Patent landscapes for pharmaceutical compounds.
- European Patent Register. (2023). Legal status and prosecution history of EP4233838.
[1] European Patent Office. (2023). European Patent Register. Retrieved from https://www.epo.org/searching-for-patents/legal/register.html
[2] WIPO. (2023). Patent landscape reports for pharmaceutical innovations. Retrieved from https://www.wipo.int/patents/en/
